Artificial intelligence (AI) is increasingly significant in the medical device sector, with over 1,000 AI-enabled devices authorized by the FDA. Key trends for 2025 include new FDA guidances encouraging pre-determined change control plans, ongoing regulatory uncertainties, and challenges such as insurance reimbursement. Experts highlight the need for thorough evaluation and monitoring of AI tools in hospitals, as well as the importance of transparency in AI model performance and costs.